Literatura científica selecionada sobre o tema "Balance inflammatoire"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Consulte a lista de atuais artigos, livros, teses, anais de congressos e outras fontes científicas relevantes para o tema "Balance inflammatoire".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Artigos de revistas sobre o assunto "Balance inflammatoire"
Buron, F., P. Malvezzi, E. Villar, C. Chauvet, B. Janbon, L. Denis, R. Cahen et al. "Effet du sirolimus sur la balance inflammatoire en transplantation rénale : étude sirilygre". Néphrologie & Thérapeutique 8, n.º 5 (setembro de 2012): 268. http://dx.doi.org/10.1016/j.nephro.2012.07.305.
Texto completo da fonteSAUVET, F., M. CHENNAOUI, S. BANZET, C. BOURRILHON, F. CANINI, L. BOURDON e N. KOULMANN. "Coup de chaleur d’exercice, système cardiovasculaire et vulnérabilité systémique". Médecine et Armées Vol. 40 No. 3, Volume 40, Numéro 3 (1 de junho de 2012): 231–40. http://dx.doi.org/10.17184/eac.6611.
Texto completo da fonteHoriuchi, I., Y. Kawano, M. Minohara e J. Kira. "Th1Th2 balance in inflammatory neurologic diseases". Journal of Neuroimmunology 90, n.º 1 (setembro de 1998): 81. http://dx.doi.org/10.1016/s0165-5728(98)91665-4.
Texto completo da fonteAdrie, Ch, e M. R. Pinsky. "The inflammatory balance in human sepsis". Intensivmedizin und Notfallmedizin 36, n.º 5 (25 de junho de 1999): 419–28. http://dx.doi.org/10.1007/s003900050260.
Texto completo da fonteAdrie, C., e M. R. Pinsky. "The inflammatory balance in human sepsis". Intensive Care Medicine 26, n.º 4 (26 de abril de 2000): 364–75. http://dx.doi.org/10.1007/s001340051169.
Texto completo da fonteTedgui, A., e Z. Mallat. "Pro- and anti-inflammatory balance and atherosclerosis". Atherosclerosis 151, n.º 1 (julho de 2000): 165. http://dx.doi.org/10.1016/s0021-9150(00)80751-0.
Texto completo da fonteHutcheson, Jack. "Adipokines influence the inflammatory balance in autoimmunity". Cytokine 75, n.º 2 (outubro de 2015): 272–79. http://dx.doi.org/10.1016/j.cyto.2015.04.004.
Texto completo da fonteFerrarelli, Leslie K. "New connections: Restoring immune balance". Science Signaling 13, n.º 661 (8 de dezembro de 2020): eabf9854. http://dx.doi.org/10.1126/scisignal.abf9854.
Texto completo da fonteWagener, Frank, Carine Carels e Ditte Lundvig. "Targeting the Redox Balance in Inflammatory Skin Conditions". International Journal of Molecular Sciences 14, n.º 5 (26 de abril de 2013): 9126–67. http://dx.doi.org/10.3390/ijms14059126.
Texto completo da fonteEsmaelzadeh, Abbas, Hassan Vosooghinia, Mohammad Reza Sheikhian, Hadi Bagheri Hosseini, Daryoush Hamidi Alamdari, Fatemeh Ahmadi, Maryam Emadzadeh e Seyed Mahdi Pakdaman Shahri. "Pro-Oxidant Antioxidant Balance in Inflammatory Bowel Disease". International Journal of Clinical Medicine 07, n.º 05 (2016): 334–41. http://dx.doi.org/10.4236/ijcm.2016.75035.
Texto completo da fonteTeses / dissertações sobre o assunto "Balance inflammatoire"
Motta, Jean-Paul. "Rôle de la balance protéolytique dans l'immunité de la muqueuse intestinale". Toulouse 3, 2012. http://thesesups.ups-tlse.fr/1883/.
Texto completo da fonteTreatment of Inflammatory Bowel Disease (IBD) represents a major medical challenge. Inflammatory processes in the gut are induced by several cells and mediators. Among them, serine proteases are mediators involved in many pathways leading to inflammation in the gut. During this thesis, we have shown that serine proteases and their inhibitors were dysregulated during IBD. On one hand, colonic biopsies from IBD patients released higher amount of proteolytic activity than healthy controls did. On the other hand, the expression of elafin mRNA (i. E. A protease inhibitor) was downregulated in the mucosa of patients suffering from IBD. We have hypothesized that gut inflammation could be reduced by re-equilibrating that balance in the gut, using elafin inhibitor. We have developed several in vivo approaches to evaluate the therapeutic properties of elafin. We used transgenic mice expressing elafin constitutively, we have used recombinant viral vectors and recombinant lactic acid bacteria to express transiently elafin in the gut during colitis. We have also evaluated in vitro the role of elafin in the physiology of human intestinal epithelial cells. Using those different approaches, we have demonstrated that elafin reduced the clinical score of colitis in different models in mice, reduced the release of pro-inflammatory cytokines, reduced immune cell infiltration and also restored epithelium homeostasis during inflammation. Those results led us to think that protease inhibitors have a promising therapeutic potential for the treatment of IBD
Tournadre, Anne. "Immunité innée, balance th1/th17 et précurseurs musculaires dans les myopathies inflammatoires". Phd thesis, Université Claude Bernard - Lyon I, 2010. http://tel.archives-ouvertes.fr/tel-00715926.
Texto completo da fonteLorvellec, Marie. "Dialogue entre le complément C1 et l'alarmine HMGB1 dans l'inflammation". Electronic Thesis or Diss., Université Grenoble Alpes, 2024. http://www.theses.fr/2024GRALV033.
Texto completo da fonteC1s protease is a central component in the initiation of the classical pathway of the complement system. It was originally believed to exclusively target proteins C2 and C4 in this proteolytic cascade. However, recent discoveries have highlighted the presence of constitutively active free C1s in certain pathologies, suggesting a broader role for this protease beyond complement activation. Among the non-canonical targets identified for C1s is the HMGB1 protein, initially described as a nuclear protein involved in chromatin condensation and gene expression.Recent studies have shown that HMGB1 can also be localized in different cellular compartments and plays a crucial role in inflammation when released into the extracellular environment. The main objective of this thesis project was to elucidate the role of C1s cleavage of HMGB1 in modulating the inflammatory response. Our work has shown that HMGB1 digestion fragments have distinct effects from the whole protein on complement activation and macrophage cytokine responses.In particular, we confirmed that the whole protein activates the classical complement pathway when bound to a surface and promotes M1 macrophage polarization in response to LPS. In contrast, fragment f2 is capable of activating the classical complement pathway, even when in solution, while fragment f3 inhibits the secretion of pro-inflammatory cytokines in cell studies. In addition, we explored the impact of cysteine redox state on the effects of HMGB1 and its fragments using mimetic mutants. HMGB1 digestion is restricted when the protein is in disulfide form, suggesting an important role of the disulfide bridge in access to the C1s digestion site. The redox forms of the whole protein do notappear to affect its ability to activate complement, while oxidized fragment f2 may lose its ability to activate it in solution. These results reveal that C1s cleavage of HMGB1 acts as an inflammation timer, orchestrating the inflammatory response through the transition from a pro-inflammatory amplification phase to a resolution phase. These findings open new perspectives for understanding the complex mechanisms of inflammation and the development of therapies for the treatment of inflammatory diseases
Gormley, Sheena Mary Catherine. "Plasma and urinary cytokine balance and renal function during cardiac surgery". Thesis, Queen's University Belfast, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.326410.
Texto completo da fonteMcLean, Gavin W. "An investigation into the balance of pro- and anti-inflammatory cytokines in cardiac surgery and hip fracture surgery". Thesis, Queen's University Belfast, 2017. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.727756.
Texto completo da fonteCabrera, Rojas Natalia. "Efficacité et tolérance des agents biologiques dans les rhumatismes inflammatoires à début juvénile dans les essais cliniques randomisés et les études observationnelles". Thesis, Lyon, 2019. http://www.theses.fr/2019LYSE1191/document.
Texto completo da fonteJuvenile inflammatory rheumatism is a chronic disease that begins before the age of 16. Includes conditions classified along a continuum, ranging from the deregulation of innate immunity to the deregulation of adaptive immunity. Juvenile idiopathic arthritis (JIA) remains the most frequently diagnosed disease. Therapeutic options have expanded since the 2000s with the development of targeted therapies: biological agents (BAs). They can be combined with standard treatments used in paediatric rheumatology (e.g. non-steroidal anti-inflammatory drugs, corticosteroids, methotrexate, and other immunosuppressive drugs). The objective of the work of this thesis was to model the benefit-risk balance of BAs used in JIA from randomized clinical trials (RCTs) and to explore long-term tolerance from observational trials. First, using a meta-analytical approach, the data from double-blind, placebo-controlled or open RCTs in JIA were analysed for modelling the benefit-risk balance of BAs. For this purpose, the efficacy measured by a composite clinical and biological score (ACRped30), was compared with clinical safety during the randomized phase of RCTs. Safety criterion was the occurrence of adverse events (AEs). The risk-benefit balance remains favourable for biotherapies. However, these results are limited by the short follow-up period, which may underestimate the incidence of AEs. Second, we conducted an observational study to investigate the medium- and long-term safety of biotherapies using AEs and serious AEs described in a retrospective multicentre database. The overall safety of biotherapies has been acceptable in children with inflammatory rheumatic diseases. We observed a variation in the SAEs over time and that the concomitant prescription of immunosuppressants represented an independent risk for the occurrence of AEs. In order to explore these elements and long-term safety, a meta-analysis of observational studies was conducted. We used the SAEs to study precisely the short and long-term tolerance
Henno, Priscilla. "Dysfonctions vasculaire et bronchique dans deux modèles de bronchopathies chroniques inflammatoires chez l’homme : tabagisme et mucoviscidose. Voies de l’endothéline-1 et de la balance NOS/arginases". Thesis, Paris Est, 2010. http://www.theses.fr/2010PEST0043.
Texto completo da fontePulmonary arteriel endothelium has a key role in the regulation of vascular tone by the release of dilating and constrictive mediators. Impairment of endothlium functions leads to a loss of the physiological equilibrium between vasoconstriction and vasodilation, together with the loss of vascular smooth muscle cells (SMC) proliferation. These alterations induce pulmonary vascular remodeling and elevation of vascular resistance which can lead to an irreversible pulmonary hypertension (PH). The role of hypoxemia is not exclusive. Airways are exposed to physical aggressions by inhaled particles, which can lead to bronchial remodeling and impaired bronchial tone and reactivity, the mediators of which can be partly shared by endothelial dysfunction.Our goal was to evaluate the existence of endothelial dysfunction as a precursor of PH in 2 models of chronic bronchopathy of opposite stages of disease severity: end-stage cystic fibrosis (CF) and tobacco smoking with or without impaired lung function. We showed that in end-stage CF pulmonary explants, endothelial dysfunction is frequent and that it was at least partly due to a vascular upregulation of the endothelin (ET)-1 pathway.Furthermore, approximately ¼ of smokers with normal or poorly impaired lung function also displayed a similar endothelial dysfunction. We studied therein 2 potential physiopathological pathways, that of ET-1 and that which governs nitric oxide (NO) synthesis: the NO synthases (NOS)/arginases balance. We showed an upregulation of ET-A receptor expression and an inverse correlation between this expression and the vasoactive response to acetylcholine (Ach). If NO has an anti mitogenic effect on SMC, the arginases pathway-competitive with the NOS- leads to tissue repair and remodeling.We studied the vascular expression of these enzymes and the pharmacological effect of NOS and arginases inhibitors on response to Ach. We showed that the expression of NOS was not deficient and that arginases did not seem to have a deleterious effect on endothelial function in this model.Concomitantly to these mechanisms leading to vascular remodeling, wr searched for a bronchial dysfunction in smokers which could antecede bronchial remodeling, a well known feature of tobacco smoking. Bronchial hyperresponsiveness is a predictive marker of airway remodeling and subsequent bronchial obstruction. The role of the NOS/arginases pathway in the control of bronchial tone is still unknown. We evaluated the bronchial expression of the NOS/arginases balance in smokers and the effects of NOS and arginases inhibitors on bronchoconstrictive response to Ach. We found that an upregulation of NOS2 expression in COPD patients is involved in airway tone regulation and functional airflow limitation, whereas increased arginase activity is involved in airway sensitivity
Costa, Fernando Oliveira. "Efeito agudo da galantamina em parâmetros hemodinâmicos e autonômicos em portadores da síndrome metabólica: estudo clínico prospectivo randomizado". Universidade Nove de Julho, 2014. http://bibliotecadigital.uninove.br/handle/tede/1152.
Texto completo da fonteMade available in DSpace on 2015-07-27T14:45:59Z (GMT). No. of bitstreams: 1 Fernando Oliveira Costa.pdf: 1199928 bytes, checksum: f721f323b7b101614061ea44e7dd6cb3 (MD5) Previous issue date: 2014-02-21
The metabolic syndrome (MetS) consists of a combination of conditions that tend to cluster together, and increase the risk of type 2 diabetes and cardiovascular disease. The components of the metabolic syndrome include central (abdominal) obesity, elevated fasting glucose, dyslipidemia (abnormally high triglycerides and low high-density lipoprotein cholesterol), and elevated blood pressure. MetS is also associated with proinflammatory and prothrombotic states, non-alcoholic liver steatosis, obstructive sleep apnea and reproduction disorders. Although a common unifying physiopathological mechanism is not known, central obesity and inflammation play a major role in MetS and upon each of its components. The MetS has reached epidemic proportions and to date there are no proven pharmacological interventions that simultaneously target all of the components of this syndrome. Inflammation plays an important role in the pathogenesis of the MetS. Recently, it was discovered that inflammation can be regulated by neural, cholinergic mechanisms and a cholinergic drug, the acetylcholinesterase inhibitor galantamine suppresses abnormal inflammation and alleviates MetS pathologies in rodents. The fact that galantamine is an approved drug, used to treat patients with Alzheimer´s disease with a known safety profile, will facilitate its clinical application in another situations. We hypothesize that treatment of subjects with the MetS with galantamine will result in alleviation in the MetS clinical conditions and inflammation. The objective of our study was to initiate an investigation on the safety profile of galantamine in MetS patients, with special attention on autonomic, hemodynamic and cognitive parameters. A randomized, double-blind, prospective study evaluated clinical, autonomic, hemodynamic and cognitive variables of patients with MetS in two moments: before treatment (basal state) and after 28 days of treatment with galantamine 8 mg daily. There was a statistical tendency in reducing systolic blood pressure in the HRV with Finometer® in patients under galantamine (124.4 ± 4 vs 119.7 ± 3.7 mmHg, basal and 28 days values, respectively) and also a reduction in diastolic blood pressure (72.5 ± 1.3 vs 67.2 ± 1.7 mmHg, basal and 28 days values, respectively). Paradoxically, an increase in the sympathetic modulation of the heart was observed with the HRV study measuring the LF (nu) value (46.2 ± 3.8 vs 57.1 ± 3.4 basal and 28 days, respectively) and a decrease in the parasympathetic modulation HF (nu) value (53.8 ± 3.8 vs 43.0 ± 3.4, basal and 28 days, respectively). We did not observe any significant change in cognitive domains. Our conclusion is that treatment with galantamine 8 mg exhibits a safe clinical profile and can be used in MetS patients.
A síndrome metabólica consiste na combinação de condições agrupadas e aumentam o risco para diabetes tipo 2 e doença cardiovascular. Seus componentes incluem obesidade central, níveis aumentados de glicose, dislipidemia caracterizada por aumento de triglicérides e baixos níveis de HDL e aumento da pressão arterial. Também está associada a um estado proinflamatório, a um estado protrombótico, a esteatose hepática não-alcoólica, apnéia obstrutiva do sono e a desordens reprodutivas. Apesar da não determinação de um mecanismo fisiopatológico unificador, obesidade central e inflamação parecem ser centrais na síndrome metabólica e nos seus componentes individuais. A síndrome metabólica tem alcançado proporções epidêmicas universais e até o presente não há intervenção farmacológica comprovada que atue simultaneamente em todos os seus componentes. Sabe-se hoje que o processo inflamatório tem um papel importante na patogenia da síndrome. Recentemente foi evidenciado que a inflamação pode ser regulada por mecanismos neurais colinérgicos, e que a galantamina, um inibidor da acetilcolinesterase, suprime a inflamação e atua nos componentes da síndrome diminuindo a patogenia em roedores. O fato de a galantamina ser uma droga já aprovada e de perfil seguro em portadores de demência facilita seu uso em outras situações clínicas. Considerando a hipótese de que a galantamina causará melhora da inflamação e dos outros distúrbios relacionados, o objetivo deste estudo foi iniciar a investigação sobre o perfil de segurança da galantamina em pacientes com síndrome metabólica, em especial, em parâmetros hemodinâmicos, autonômicos e de cognição. Realizamos um estudo prospectivo, duplo-cego e randomizado, que avaliou os dados clínicos e os parâmetros descritos, no momento basal e após 28 dias de uso de galantanima (8mg por dia), em portadores de síndrome metabólica. Houve uma tendência à redução da PAS, avaliada batimento-a-batimento com o Finometer no grupo que usou galantamina (124,4 ± 4 vs 119,7 ± 3,7 mmHg, respectivamente basal e após 28 dias de uso, p=0,04), o mesmo ocorrendo com a PAD (72,5 ± 1,3 vs 67,2 ± 1,7, p=0,005), respectivamente basal e após 28 dias de uso). De forma paradoxal, ocorreu um aumento da atividade simpática na modulação autonômica para o coração, avaliada por meio do estudo da variabilidade da freqüência cardíaca como atestado por um valor LF (nu) (46,2 ± 3,8 vs 57,1 ± 3,4 , p=0,0005)), e redução da modulação parassimpática, representada pelo valor do HF (nu) (53,8 ± 3,8 vs 43,0 ± 3,4, p=0,0005) respectivamente basal e após 28 dias de uso. Não observamos alterações significativas nos testes que avaliam o domínio cognitivo dos indivíduos. Concluímos que a dose utilizada de galantamina tem um perfil de segurança clínica que permite expandir seu uso em pacientes portadores de síndrome metabólica.
Werncke, Daíse. "Relação entre restrição nutricional e acidose ruminal com as alterações na produção e composição do leite". reponame:Biblioteca Digital de Teses e Dissertações da UFRGS, 2017. http://hdl.handle.net/10183/163326.
Texto completo da fonteThe study consisted of two experiments with the aim of evaluating the effects of ruminal acidosis and nutritional restriction on the occurrence of inflammatory processes in animals and correlate with changes in milk production and composition. Twelve Holstein and cross bred Holstein and Jersey cows were used. In the first study, in the adaptation phase, the animals received a diet formulated to supply 100% of the nutritional needs of energy and protein. In the induction, a diet composed by 50% restriction of energy and protein requirements was administered. In the recuperation, the animals received one of the three experimental diets to recover milk stability: (1) only energy supply; (2) supply only of protein; (3) supply of energy and protein. The nutritional restriction in energy and / or protein can affects negatively milk production, weight and condition score body. In addition to reduce the efficiency of protein utilization of the diet and cause greater instability of the milk to the alcohol test. However, it does not changed the blood and metabolic profile. In second study, the animals were divided into two groups (1) control and (2) acidosis. The experimental design was simple reversible with two treatments and two experimental periods. Physiochemical characteristics, health of the mammary gland, physiological measures, metabolic profile and blood parameters were analyzed. Losses in milk production, reduction of alcohol stability test, urinary pH, fecal pH, ruminal pH were caused by Subacute ruminal acidosis (SARA) induction. However, induction of SARA did not changed the blood parameters evaluated. SARA changes the physical-chemical characteristics of the milk, without influencing the acute phase proteins concentrations, characterizing an inflammatory response. SARA can affect the animals without demostrate changes in the blood profile of the animals.
Bäck, Christer Matthias [Verfasser], Uwe [Akademischer Betreuer] Conrath e Frank [Akademischer Betreuer] Tacke. "MCP-1 dependent balance of inflammatory pathways and interplay of immune cells in the liver during injury, fibrosis and injury regression : unterschiedliche MCP-1-abhängige Entzündungsmechanismen und Interaktionen von Immunzellen in der Leber / Christer Matthias Bäck ; Uwe Conrath, Frank Tacke". Aachen : Universitätsbibliothek der RWTH Aachen, 2015. http://d-nb.info/1129787419/34.
Texto completo da fonteLivros sobre o assunto "Balance inflammatoire"
Farmer, Jenna. Managing IBD: A Balanced Guide to Inflammatory Bowel Disease. Hammersmith Health Books, 2017.
Encontre o texto completo da fonteLundin, Mia, e Ulrika Davidsson. Hormone Balance Cookbook: 60 Anti-Inflammatory Recipes to Regulate Hormonal Balance, Lose Weight, and Improve Brain Function. Skyhorse Publishing Company, Incorporated, 2018.
Encontre o texto completo da fonteThe hormone balance cookbook: 60 anti-inflammatory recipes to regulate hormonal balance, lose weight, and improve brain function. 2018.
Encontre o texto completo da fonteHolmes, Aubree, Carla Choy e Alyssa Yuhas. Way We Eat: Finding Balance and Nourishment Through Delicious Anti-Inflammatory Cooking. Aubree Holmes, LLC, 2024.
Encontre o texto completo da fonteGünşen, Uğur, e Ramazan Mert Atan. Role of Nutrition in Providing Pro-/Anti-Inflammatory Balance: Emerging Research and Opportunities. IGI Global, 2020.
Encontre o texto completo da fonteAtan, Ramazan Mert, e Uğur Günşen. Role of Nutrition in Providing Pro-/Anti-Inflammatory Balance: Emerging Research and Opportunities. IGI Global, 2020.
Encontre o texto completo da fonteGünşen, Uğur, e Ramazan Mert Atan. Role of Nutrition in Providing Pro-/Anti-Inflammatory Balance: Emerging Research and Opportunities. IGI Global, 2020.
Encontre o texto completo da fonteAtan, Ramazan Mert, e Uğur Günşen. Role of Nutrition in Providing Pro-/Anti-Inflammatory Balance: Emerging Research and Opportunities. IGI Global, 2020.
Encontre o texto completo da fonteSenger, Lillian. New Anti-Inflammatory Cookbook 2022: Recipes to Lose Weight, Balance Hormones and Reverse Disease. Independently Published, 2022.
Encontre o texto completo da fonteMaclachlan, Rosie. Complete Anti-Inflammatory Cookbook: 498 Quick and Simple Anti-Inflammatory Recipes, Reduce Inflammation, Balance Hormones and Lose Weight. Including 28-Days Meal Plan. Independently Published, 2022.
Encontre o texto completo da fonteCapítulos de livros sobre o assunto "Balance inflammatoire"
Kang, Melissa, e Temitope O. Keku. "Single Nucleotide Polymorphisms in Obesity and Inflammatory Genes in African Americans with Colorectal Cancer". In Impact of Energy Balance on Cancer Disparities, 131–63. Cham: Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-06103-0_7.
Texto completo da fonteVetter, Douglas E., e Kathleen T. Yee. "Corticotropin Releasing Factor Signaling in the Mammalian Cochlea: An Integrative Niche for Cochlear Homeostatic Balance Against Noise". In Inflammatory Mechanisms in Mediating Hearing Loss, 31–60. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-92507-3_3.
Texto completo da fonteAl Marmour, Doha. "The Medicinal Importance of the Indian Spice Plant, Curry Leaves Murraya Koenigii". In Medicinal Spices, 143–52. Istanbul: Nobel Tip Kitabevleri, 2024. http://dx.doi.org/10.69860/nobel.9786053359340.9.
Texto completo da fonteGunes Kocinkag, Vezire, e Muhammed Kocinkag. "Medical Use of Cardamom (Elettaria Cardamomum L.)". In Medicinal Spices, 239–46. Istanbul: Nobel Tip Kitabevleri, 2024. http://dx.doi.org/10.69860/nobel.9786053359340.15.
Texto completo da fonteKonsman, Jan Pieter, e Rainer H. Straub. "Energy Balance and Neuroendocrine-Immune Regulation in Chronic Inflammatory and Neoplastic Diseases: An Evolutionary Perspective". In Masterclass in Neuroendocrinology, 323–42. Cham: Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-21358-8_13.
Texto completo da fonteTahseen, Rabia, Mohammad Parvez, G. Sravan Kumar e Parveen Jahan. "Prognostic Importance of Th1:Th2 (IL-1β/IL-10) Cytokine Ratio in Adult Onset-Bronchial Asthma". In Proceedings of the Conference BioSangam 2022: Emerging Trends in Biotechnology (BIOSANGAM 2022), 176–87. Dordrecht: Atlantis Press International BV, 2022. http://dx.doi.org/10.2991/978-94-6463-020-6_18.
Texto completo da fonteBatu, Ozlem. "Oxytocin". In Brain Biochemistry and Its Disease, 23–38. Istanbul: Nobel Tip Kitabevleri, 2024. http://dx.doi.org/10.69860/nobel.9786053359371.2.
Texto completo da fonteCetik Yildiz, Songul. "Brain and Oxidative Stress". In Brain Biochemistry and Its Disease, 149–65. Istanbul: Nobel Tip Kitabevleri, 2024. http://dx.doi.org/10.69860/nobel.9786053359371.9.
Texto completo da fonteNasa, Prashant, Rajesh Kumar, Deven Juneja e Supradip Gosh. "The Case for Albumin as Volume Expander and beyond". In Rational Use of Intravenous Fluids in Critically Ill Patients, 227–42. Cham: Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-42205-8_10.
Texto completo da fonteHatipoglu, Abdulkerim. "Brain and Nutrition". In Brain Biochemistry and Its Disease, 109–30. Istanbul: Nobel Tip Kitabevleri, 2024. http://dx.doi.org/10.69860/nobel.9786053359371.7.
Texto completo da fonteTrabalhos de conferências sobre o assunto "Balance inflammatoire"
Dinatt, Roberto Fontella, Bruna Zorzo Marques, Paloma Trevisan Vogel e Lucas Cardeal de Oliveira. "Analysis of the importance of a balanced diet to prevent diseases associated with aging". In III Seven International Medical and Nursing Congress. Seven Congress, 2024. http://dx.doi.org/10.56238/iiicongressmedicalnursing-051.
Texto completo da fonteSaber Hmimass, M., Driss Azzouzi, Mohamed Borahma, Maryeme Kadiri, Fatima Zahra Chabib, Camelia Berhili, Nawal Lagdali e Fatima Zahra Ajana. "P319 The etiological profile of chronic disturbances of the liver balance during chronic inflammatory bowel diseases". In BSG LIVE’24, 17-20 June 2024, ICC Birmingham. BMJ Publishing Group Ltd and British Society of Gastroenterology, 2024. http://dx.doi.org/10.1136/gutjnl-2024-bsg.401.
Texto completo da fonteLiu, Xiaoqing, Nalin Lai, Ting Cheng, Xiaojuan Mao e LI Xiaofeng. "AB0470 IMMUNOREGULATORY THERAPY EFFECTIVELY PROMOTES THE BALANCE BETWEEN TREG CELLS AND PRO-INFLAMMATORY LYMPHOCYTES IN SYSTEMIC LUPUS ERYTHEMATOSUS". In Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2019-eular.2151.
Texto completo da fontePetrović, Miloš, Radojica Đoković, Vladimir Kurćubić, Snežana Bogosavljević-Bošković, Simeon Rakonjac e Milun Petrović. "Intracellular and extracellular Hsp70 in cows: Similarities and differences in physiological and pathophysiology conditions". In Zbornik radova 26. medunarodni kongres Mediteranske federacije za zdravlje i produkciju preživara - FeMeSPRum. Poljoprivredni fakultet Novi Sad, 2024. http://dx.doi.org/10.5937/femesprumns24025p.
Texto completo da fonteBalajadia, Januaria M., Lori Shimoda, William Greineisen e Helen Turner. "Abstract 2884: ER stress and autophagy induced in pro-inflammatory mast cells exposed to stimuli associated with a positive energy balance." In Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.am2013-2884.
Texto completo da fonteNakstad, Britt, e Torstein Lyberg. "LOCAL ACTIVATION OF COAGULATION AND FIBRINOLYSIS IN LUNG DISEASE IS REFLECTED IN BR0NCH0ALVE0LAR LAVAGE FLUID". In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643054.
Texto completo da fonteMuhammad, Shayma, Suhaila Darogha e Ahmed A Al-Naqsbbandi. "Association of IL-18 Promoter -607 C/A Polymorphism with Severity of Covid-19 in Kurdish Patients". In 5th International Conference on Biomedical and Health Sciences. Cihan University-Erbil, 2024. http://dx.doi.org/10.24086/biohs2024/paper.1448.
Texto completo da fonteSazdova, Lyubomira. "ASPECTS OF PHYSIOTHERAPY AFTER NONOPERATIVE TREATMENT OF LATERAL ANKLE SPRAIN". In INTERNATIONAL SCIENTIFIC CONGRESS “APPLIED SPORTS SCIENCES”. Scientific Publishing House NSA Press, 2022. http://dx.doi.org/10.37393/icass2022/148.
Texto completo da fonteUeno, Augusto Yoshiro, Ivo Emilio da Cruz Jung, Ivana Beatrice Mânica da Cruz e Fernanda Barbisan. "Depression and psychological distress in elders are influenced by the antioxidant enzyme SOD2". In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.003.
Texto completo da fonteAhmed, Saad, Zackary Harris e Russell David Levi. "Relationship Between Gut Microbiota and Dementia". In 28th Annual Rowan-Virtua Research Day. Rowan University Libraries, 2024. http://dx.doi.org/10.31986/issn.2689-0690_rdw.stratford_research_day.90_2024.
Texto completo da fonteRelatórios de organizações sobre o assunto "Balance inflammatoire"
Liu, Yangjun, Wei Xie, Zbigniew Ossowski, Juan Li, Juan Yang, Yiming Luo, Xia Wu e Liying Liu. Physical activity, abdominal obesity and inflammatory response in the elderly: a systematic review and meta-analysis of randomized-controlled trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, março de 2023. http://dx.doi.org/10.37766/inplasy2023.3.0051.
Texto completo da fonte